Canada-based, a pioneering biotech company renowned for its unique Q-peptide platform technology, raised USD 500,000 in investment funding. The round took place on March 11, 2024. The Ontario Centre of Innovation’s (OCI) Life Science Innovation Fund led the financing for the company. The investment is in addition to a co-investment of USR 850,000 for a total round size of USD 1,350,000.
Purpose of financing for Quthero
With the latest investment, the company seeks to expand its operations.
What the company’s official has to add
Milica Radisic, PhD, President and CEO of Quthero, said, “We are excited to have OCI’s investment in Quthero, which will allow the company to launch our dermatological post-procedure products. These products are designed to enhance patient experience and speed up recovery after aesthetics procedures such as microcoring and radio frequency microneedling.”
What the investors and other experts have to comment
Vic Fedeli, Ontario’s Minister of Economic Development, Job Creation and Trade, said, “Through the Ontario Life Sciences Innovation Fund, our government is ensuring that Ontario companies, like Quthero, have the resources they need to develop cutting-edge solutions. We congratulate Quthero on the success of their unique Q-peptide platform technology and thank them for their contributions to Ontario’s life sciences sector.”
In addition, Claudia Krywiak, President and CEO of the Ontario Centre of Innovation, said, “Quthero’s groundbreaking technology has the potential to transform lives. The company’s patented Q-peptide platform is versatile in its applications. OCI is proud to support the development and commercialization of this technology. This investment demonstrates our commitment to advancing innovative solutions that contribute to Ontario’s thriving innovation sector and beyond.”
OCI is well known for encouraging cooperation between partners in the public, private, and academic domains. To maximize the benefits of innovation for Ontario and Canada, OCI strategically funds R&D, technology innovation, and commercialization projects. Serving as an ecosystem connector, OCI creates and maintains industry-academic partnerships that are successful, supports high-potential SMEs in commercializing ground-breaking research, and offers opportunities for the next generation of highly skilled talent to gain practical training and skill development.
About the company
Quthero is using its unique Q-peptide technology to find and develop novel applications for tissue regeneration that are safe, efficient, and reasonably priced. Quthero has developed a number of applications by utilizing the capabilities of its proprietary Q-peptide platform technology. Quthero’s products can be purchased directly from their website, www.quthero.com, or through partnering physicians. Quthero’s solutions have been shown to speed up healing, lessen redness and bruising, and avoid scarring following cosmetic treatments.
To explore more such startups, visit Zefyron Startup Database
For more extensive analysis and Market Intelligence reports, feel free to approach us.
We try our best to fact-check and bring well-researched as well as non-plagiarized content to you. Please let us know
if there are any discrepancies in any of our published stories,
-how we can improve,
-what stories you would like us to cover
–what information you are looking for in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by!
Next Article
